Background Albumin eye drops (AED) can be effective in the healing of corneal epithelial defects. Albumin is the main protein component of autologous serum and therefore may be useful in the treatment of ocular surface diseases such as corneal ulcers and epithelial defects. Aim This work aimed to study the effect of human AED as adjunctive therapy in the treatment of persistent corneal epithelial defects (PCEDs). Patients and methods This prospective study was conducted in 20 patients aged 18–60 years, of both sexes, with PCEDs that did not respond to standard medical treatment for 10 to 14 days. All patients underwent slit-lamp examination, fundus examination, intraocular pressure measurement (digital), corneal swab, culture, and sensitivity. Results There was a significant positive correlation between the duration of medical therapy with the persistent antiepithelial defect AED and the size of the persistent epithelial defect at presentation (P<0.05). There was significant improvement in pain sensation, ciliary injection, persistent epithelial defect size, corneal, and stromal infiltration during the study period. There was no significant association between the duration of continuous ant epithelial drug therapy AED and stromal infiltration at presentation (P=0.627). Conclusion The promising therapeutic effects of AED on the corneal epithelium have been demonstrated. Albumin has shown a therapeutic effect in the treatment of PCEDs.
Read full abstract